Portuguese pharmaceutical group FHC will use its acquisition of Activo Health to build its African footprint, beginning with a push into South Africa’s sterile injectables market, senior executives said yesterday. The privately held group bought Activo Health from JSE-listed Afrocentric. FHC owns Laboratórios Basi, a drugmaker based in Mortágua, Portugal, which reported turnover of about €543m (roughly R10bn) in 2025.…
Tag: Activo Health
-
AfroCentric Divests Activo Health In Strategic Shift Toward Services
AfroCentric Investment Corporation, a Johannesburg Stock Exchange-listed healthcare firm, has announced the sale of its pharmaceutical unit, Activo Health, to Portuguese pharmaceutical giant FHC Group. This sale marks a pivotal shift in AfroCentric’s operational focus. The group is moving away from pharmaceutical manufacturing and marketing. AfroCentric Divests Activo Health In Portfolio Overhaul AfroCentric’s subsidiary, ACT Healthcare Assets, entered into an…